相关实验视频

Updated: Sep 11, 2025

Minimally Invasive Isolated Limb Perfusion (MI-ILP) for Locally Advanced Melanomas and Sarcomas of the Extremity

Minimally Invasive Isolated Limb Perfusion (MI-ILP) for Locally Advanced Melanomas and Sarcomas of the Extremity

Published on: January 31, 2025

晚发黑色素瘤患者的免疫相关不良事件:晚期研究

Javier Pozas^1,2, Sowmya Cheruvu¹, Poorni Priya Jaganathan¹

¹Department of Medical Oncology, The Royal Marsden Hospital NHS Foundation Trust, London SW3 6JJ, UK.

|August 14, 2025

概括

晚期发生的免疫相关不良事件 (irAEs) 影响了近15%的晚期黑色素瘤患者接受免疫检查点抑制剂治疗. 这些延迟的毒性需要谨慎管理,对生物标志物和风险因素的进一步研究至关重要.

科学领域:

在瘤学瘤学.
免疫学免疫学免疫学
皮肤病学皮肤病学

背景情况:

免疫检查点抑制剂 (ICI) 已经彻底改变了先进的黑色素瘤治疗,改善了生存率.
然而,ICI会引起与免疫相关的不良事件 (irAEs),而晚发的irAEs还没有得到研究.
早期出现的毒性很好地表征,但在治疗停止后出现的延迟的irrAEs经常被忽视.

研究的目的:

在接受ICI的晚期黑色素瘤患者中调查晚期发作的irAEs的发生率和特征.
解决治疗完成后显著表现的毒性方面的知识差距.

主要方法:

一项回顾性多中心研究,涉及246名用ICI治疗的晚期黑色素瘤患者.
晚发性IRE被定义为ICI治疗后至少3个月发生的事件.

主要成果:

近15%的患者出现了晚期发病的irrAEs,包括皮疹,大肠炎,肝炎和关节炎.
这些事件通常需要全身类固醇治疗来管理.
在高达2%的患者中,观察到超晚发的IRE (治疗后≥12个月).

结论:

晚发性IRE是ICI治疗的晚发性黑色素瘤患者的一个重大临床问题.
需要前性研究来确定风险因素,评估生活质量影响,并开发预测生物标志物.
进一步的研究对于优化延迟IRE的管理至关重要.

关键词:

晚期的黑色素瘤是什么免疫检查点抑制剂免疫检查点抑制剂晚期发生的毒性.

更多相关视频

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis

Published on: March 8, 2022

A 3D Organotypic Melanoma Spheroid Skin Model

A 3D Organotypic Melanoma Spheroid Skin Model

Published on: May 18, 2018

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Skin Cancer

Skin Cancer

Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...

Cell-mediated Immune Responses

Cell-mediated Immune Responses